84 Auditory Rehabilitation in Neurofibromatosis Type 2

May 13, 2020 by in NEUROSURGERY Comments Off on 84 Auditory Rehabilitation in Neurofibromatosis Type 2

10.1055/b-0039-169238 84 Auditory Rehabilitation in Neurofibromatosis Type 2Daniel S. Roberts, Steven R. Otto, Marc S. Schwartz, and Eric P. Wilkinson 84.1 Introduction Owing to the presence of bilateral vestibular schwannomas…

read more

82 Radiosurgery and Radiotherapy for Neurofibromatosis Type 2 Focusing on Vestibular Schwannoma

May 13, 2020 by in NEUROSURGERY Comments Off on 82 Radiosurgery and Radiotherapy for Neurofibromatosis Type 2 Focusing on Vestibular Schwannoma

10.1055/b-0039-169236 82 Radiosurgery and Radiotherapy for Neurofibromatosis Type 2 Focusing on Vestibular SchwannomaAmparo Wolf and Douglas Kondziolka 82.1 Introduction Neurofibromatosis type 2 (NF2) is an autosomal dominant disease with an…

read more

80 Natural History of Vestibular Schwannoma Growth and Hearing in Neurofibromatosis Type 2

May 13, 2020 by in NEUROSURGERY Comments Off on 80 Natural History of Vestibular Schwannoma Growth and Hearing in Neurofibromatosis Type 2

10.1055/b-0039-169234 80 Natural History of Vestibular Schwannoma Growth and Hearing in Neurofibromatosis Type 2Michel Kalamarides, Matthieu Peyre, Daniele Bernardeschi, and Olivier Sterkers 80.1 Introduction Bilateral vestibular schwannomas (VSs) are the…

read more

78 Genetics of Neurofibromatosis Type 2

May 13, 2020 by in NEUROSURGERY Comments Off on 78 Genetics of Neurofibromatosis Type 2

10.1055/b-0039-169232 78 Genetics of Neurofibromatosis Type 2Simon K. W. Lloyd and D. Gareth R. Evans 78.1 Introduction Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder characterized by the development…

read more
Get Clinical Tree app for offline access